Home/DiaMedica Therapeutics/Rick Pauls

RP

Rick Pauls

President & Chief Operating Officer

DiaMedica Therapeutics

Therapeutic Areas

Obstetrics & Gynecology Neurology Nephrology

DiaMedica Therapeutics Pipeline

Drug	Indication	Phase
DM199 (rinvecalinase alfa)	Preeclampsia (PE)	Phase 2

Leadership Team at DiaMedica Therapeutics

Chief Executive Officer

Veronica (Ronnie) Jenkins

Chief Financial Officer

Chief Medical Officer

Katherine (Kate) Rielly

General Counsel

View full DiaMedica Therapeutics profile